Andolast [132640-22-3]

TargetMol Chemicals

Andolast [132640-22-3]

72

132640-22-3

Research Use Only

Andolast

C15H11N9O

333.31

Andolast, also known as CR-2039, an anti-allergic agent for the treatment of bronchial asthma, chronic obstructive pulmonary disease (COPD). Andolast acts at different cellular levels to inhibit immunoglobulin E synthesis. Andolast proved to be significantly more effective than placebo in improving airflow, and in controlling asthma symptoms both during day and night.

3 years

O=C(Nc1ccc(cc1)-c1nnn[nH]1)c1ccc(cc1)-c1nnn[nH]1

-20°C

12352200